Hypertriglyceridemia in the Genomic Era: A New Paradigm
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemia (HTG) is a highly prevalent condition that is associated with increased cardiovascular disease risk. HTG may arise as a result of defective metabolism of triglyceride-rich lipoproteins and their remnants, ie, impaired clearance, or increased production, or both. Current categorization of HTG segregates primary and secondary cases, implying genetic and nongenetic causes for each category. Many common and rare variants of the genes encoding factors involved in these pathways have been identified. Although monogenic forms of HTG do occur, most cases are polygenic and often coexist with nongenetic conditions. Cumulative, multiple genetic variants can increase the risks for HTG, whereas environmental and lifestyle factors can force expression of a dyslipidemic phenotype in a genetically susceptible person. HTG states are therefore best viewed as a complex phenotype resulting from the interaction of cumulated multiple susceptibility genes and environmental stressors. In view of the heterogeneity of the HTG states, the absence of a unifying metabolic or genetic abnormality, overlap with the metabolic syndrome and other features of insulin resistance, and evidence in some patients that accumulation of numerous small-effect genetic variants determines whether an individual is susceptible to HTG only or to HTG plus elevated low-density lipoprotein cholesterol, we propose that the diagnosis of primary HTG and further delineation of familial combined hyperlipidemia from familial HTG is neither feasible nor clinically relevant at the present time. The hope is that with greater understanding of genetic and environmental causes and their interaction, therapy can be intelligently targeted in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mendelian randomization studies also suggest that the association between plasma TGs and the risk of CHD may be causal; however, this evidence must be interpreted with caution because nearly all variants associated with TGs are also associated with HDL-C, LDL-C, or Lp(a) [56-59].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [57]
Citations
Cites
1 retracted
Doolittle, M. H., Neher, S. B., Ben-Zeev, O., Ling-liao, J., Gallagher, C. M., Hosseini, M., Yin, F., Wong, H., Walter, P., & Péterfy, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049395 · Cited by 29
RetractedThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,443
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873
Clinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
Self-citationA Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 469
Self-citationMoulin, P., Dufour, R., Averna, M., Arca, M., Cefalù, A. B., Noto, D., D'Erasmo, L., Di Costanzo, A., Marçais, C., Alvarez-Sala Walther, L. A., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.814 · Cited by 247
Causes and consequences of hypertriglyceridemia
Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239
Xiao, C., Dash, S., Morgantini, C., Hegele, R. A., & Lewis, G. F. (2016) · Diabetes · doi:10.2337/db16-0046 · Cited by 212
“the cumulative effects of the polygenic susceptibility and multiple environmental burdens may each increase the risks for the development of HTG (34).”
BackgroundSelf-citationRole of lipoprotein lipase in lipid metabolism
Olivecrona, G. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000297 · Cited by 189
Familial chylomicronemia syndrome: an under‐recognized cause of severe hypertriglyceridaemia
Baass, A., Paquette, M., Bernard, S., & Hegele, R. A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13016 · Cited by 144
Self-citationA Comprehensive Update on the Chylomicronemia Syndrome
Goldberg, R. B., & Chait, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.593931 · Cited by 117
Genetics of Triglycerides and the Risk of Atherosclerosis
Dron, J. S., & Hegele, R. A. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0667-9 · Cited by 110
Self-citationRegulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms
Xiao, C., Stahel, P., & Lewis, G. F. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.015 · Cited by 106
Self-citationTriglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0745-6 · Cited by 90
Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword?
Brouwers, M. C. G. J., Jacobs, C., Bast, A., Stehouwer, C. D. A., & Schaper, N. C. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.08.004 · Cited by 90
Rabacchi, C., Pisciotta, L., Cefalù, A. B., Noto, D., Fresa, R., Tarugi, P., Averna, M., Bertolini, S., & Calandra, S. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.815 · Cited by 76
Borén, J., Watts, G. F., Adiels, M., Söderlund, S., Chan, D. C., Hakkarainen, A., Lundbom, J., Lundbom, N., Matikainen, N., Kahri, J., et al. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305614 · Cited by 72
Metelskaya, V. A., Shalnova, S. A., Деев, А. Д., Nv, P., Gomyranova, N. V., Litinskaya, O. A., Евстифеева, С. Е., Artamonova, G. V., Гатагонова, Т. М., Grinshtein, Y. I., et al. (2016) · Russian Journal of Preventive Medicine · doi:10.17116/profmed201619115-23 · Cited by 95
Wolska, A. T., Lo, L., Sviridov, D. O., Pourmousa, M., Pryor, M., Ghosh, S. S., Kakkar, R. K., Davidson, M., Wilson, S. R., Pastor, R. W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7905 · Cited by 70
Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes
D’Erasmo, L., Costanzo, A. D., Cassandra, F., Minicocci, I., Polito, L., Montali, A., Ceci, F., & Arca, M. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313401 · Cited by 77
The contribution of GWAS loci in familial dyslipidemias
Ripatti, P., Rämö, J. T., Söderlund, S., Surakka, I., Matikainen, N., Pirinen, M., Pajukanta, P., Sarin, A.-P., Service, S. K., Laurila, P.-P., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006078 · Cited by 60
“Our study supports the hypothesis that FCH is a genetically heterogeneous disease, reflected by its heterogeneous lipid phenotype [18–20].”
Lai, C., Wojczynski, M. K., Parnell, L. D., Hidalgo, B., Irvin, M. R., Aslibekyan, S. W., Province, M. A., Absher, D., Arnett, D. K., & Ordovás, J. M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069948 · Cited by 62
The polygenic nature of mild-to-moderate hypertriglyceridemia
Dron, J. S., Wang, J., McIntyre, A. D., Cao, H., & Hegele, R. A. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.01.003 · Cited by 58
Self-citationFamilial Combined Hyperlipidemia: Current Knowledge, Perspectives, and Controversies
Bello-Chavolla, O. Y., Kuri-García, A., Ríos-Ríos, M., Vargas-Vázquez, A., Cortés-Arroyo, J. E., Tapia-González, G., Cruz-Bautista, I., & Aguilar-Salinas, C. A. (2018) · Revista de Investigación Clínica · doi:10.24875/ric.18002575 · Cited by 53
Combined dyslipidemia in childhood
Kavey, R.-E. W. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.06.008 · Cited by 66
Apolipoprotein C-II: the re-emergence of a forgotten factor
Wolska, A., Reimund, M., & Remaley, A. T. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000680 · Cited by 52
Hypertriglyceridemia in Obese Children and Adolescents
Jung, M. K., & Yoo, E.-G. (2018) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2018.27.3.143 · Cited by 52
Oral Glucose Mobilizes Triglyceride Stores From the Human Intestine
Xiao, C., Stahel, P., Carreiro, A. L., Hung, Y.-H., Dash, S., Bookman, I. D., Buhman, K. K., & Lewis, G. F. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.002 · Cited by 49
Self-citationCurrent Diagnosis and Management of Primary Chylomicronemia
Okazaki, H., Gotoda, T., Ogura, M., Ishibashi, S., Inagaki, K., Daida, H., Hayashi, T., Hori, M., Masuda, D., Matsuki, K., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17054 · Cited by 48
Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy
Gaudet, D., Drouin‐Chartier, J., & Couture, P. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.12.019 · Cited by 46
Vieira, D. A. D. S., Sales, C. H., César, C. L. G., Marchioni, D. M. L., & Fisberg, R. M. (2018) · Nutrients · doi:10.3390/nu10030314 · Cited by 45
Severe hypertriglyceridemia: Existing and emerging therapies
Malick, W. A., Do, R., & Rosenson, R. S. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108544 · Cited by 40
Glucose and GLP-2 (Glucagon-Like Peptide-2) mobilize intestinal triglyceride by distinct mechanisms
Stahel, P., Xiao, C., Davis, X., Tso, P., & Lewis, G. F. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313011 · Cited by 36
Self-citationZuurbier, L. C., Defesche, J. C., & Wiegman, A. (2021) · Genes · doi:10.3390/genes12081168 · Cited by 40
Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks
Shemesh, E., & Zafrir, B. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s188856 · Cited by 45
Role of the Gut in Diabetic Dyslipidemia
Stahel, P., Xiao, C., Nahmias, A., & Lewis, G. F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00116 · Cited by 42
Self-citationEsteve-Luque, V., Padró‐Miquel, A., Fanlo‐Maresma, M., Corbella, E., Corbella, X., Pintó, X., & Candás‐Estébanez, B. (2021) · Nutrients · doi:10.3390/nu13020552 · Cited by 39
Lee, H., Kim, Y., & Park, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-23074-2 · Cited by 42
Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies
Dib, I., Khalil, A., Chouaib, R., El-Makhour, Y., & Noureddine, H. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06071-5 · Cited by 40
Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization
Xiao, C., Stahel, P., Nahmias, A., & Lewis, G. F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01604 · Cited by 39
Self-citationEsparza, M. I., Li, X., ADAMS-HUET, B. A., Vasandani, C., Vora, A., Das, S. R., Garg, A., & Ahmad, Z. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00129 · Cited by 38
Paragh, G., Németh, Á., Harangi, M., Banach, M., & Fülöp, P. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01631-z · Cited by 38
Pediatric Dyslipidemia—Beyond Familial Hypercholesterolemia
Lazarte, J., & Hegele, R. A. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.03.020 · Cited by 32
Self-citationUnderstanding Hypertriglyceridemia: Integrating Genetic Insights
Alves, M., Laranjeira, F., & Correia‐da‐Silva, G. (2024) · Genes · doi:10.3390/genes15020190 · Cited by 44
Esfandiar, Z., Hosseini‐Esfahani, F., Mirmiran, P., Habibi-Moeini, A. S., & Azizi, F. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2059-0 · Cited by 31
New approaches to triglyceride reduction: is there any hope left?
Filtz, A., Parihar, S., Greenberg, G. S., Park, C. M., Scotti, A., Lorenzatti, D., Badimon, J. J., Soffer, D. E., Toth, P. P., Lavie, C. J., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100648 · Cited by 26
“The liver oxidizes the FA in TG via the beta-oxidation pathway or packages them back into VLDL, which are then secreted into the bloodstream [2,8].”
BackgroundCefalu, A. B., Spina, R., Noto, D., Ingrassia, V., Valenti, V., Giammanco, A., Fayer, F., Misiano, G., Cocorullo, G., Scrimali, C., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.01.003 · Cited by 28
Li, X., Pu, N., Chen, W., Shi, X., Zhang, G., Ke, L., Ye, B., Tong, Z., Wang, Y., Liu, C., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01249-z · Cited by 27
Ford, B. E., Chachra, S. S., Rodgers, K., Moonira, T., Al‐Oanzi, Z. H., Anstee, Q. M., Reeves, H. L., Schattenberg, J. M., Fairclough, R. J., Smith, D. M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101722 · Cited by 29
Managing dyslipidemia in patients with Type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1912734 · Cited by 32
Volanesorsen for treatment of familial chylomicronemia syndrome
Lazarte, J., & Hegele, R. A. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.1955348 · Cited by 26
Self-citationLamíquiz-Moneo, I., Blanco-Torrecilla, C., Bea, A. M., Mateo‐Gállego, R., Pérez‐Calahorra, S., Baila-Rueda, L., Cenarro, A., Civeira, F., & de Castro-Orós, I. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0251-2 · Cited by 30
Lewis, G. F., & Hegele, R. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00284-9 · Cited by 27
Self-citationXiao, C., Stahel, P., Morgantini, C., Nahmias, A., Dash, S., & Lewis, G. F. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13839 · Cited by 23
Self-citationThe nature and characteristics of hypertriglyceridemia in a large cohort with type 2 diabetes
Echegoyen, F. F. B., Szeto, A., Mendez, A. J., Garg, R., & Goldberg, R. B. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108387 · Cited by 25
Nguyen, N. T., Nath, P. V., Mai, V. Q., Shakir, M. K. M., & Hoang, T. D. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2021.01.006 · Cited by 22
Guo, J., Miao, G., Zhang, W., Shi, H., Lai, P., Xu, Y., Zhang, L., Chen, G., Han, Y., Zhao, Y., et al. (2024) · Theranostics · doi:10.7150/thno.91084 · Cited by 22
Polygenic Risk for Hypertriglyceridemia Can Mimic a Major Monogenic Mutation
Stahel, P., Xiao, C., Hegele, R. A., & Lewis, G. F. (2017) · Annals of Internal Medicine · doi:10.7326/l17-0182 · Cited by 20
Self-citationGLP-2 regulation of intestinal lipid handling
Mukherjee, K., & Xiao, C. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1358625 · Cited by 22
Self-citationAncestry-specific profiles of genetic determinants of severe hypertriglyceridemia
Gill, P. K., Dron, J. S., Dilliott, A. A., McIntyre, A. D., Cao, H., Wang, J., Movsesyan, I., Malloy, M. J., Pullinger, C. R., Kane, J. P., et al. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.11.007 · Cited by 20
Self-citationMajeed, M. A., Mundkur, L., Paulose, S., & Nagabhushanam, K. (2022) · Food & Function · doi:10.1039/d2fo01862d · Cited by 20
Novel therapies for severe dyslipidemia originating from human genetics
Gaudet, D. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000281 · Cited by 18
Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia
Matsunaga, A., Nagashima, M., Yamagishi, H., & Saku, K. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.51540 · Cited by 22
Cruz‐Bautista, I., Huerta‐Chagoya, A., Moreno-Macías, H., Rodríguez-Guillén, R., Ordóñez-Sánchez, M. L., Segura-Kato, Y., Mehta, R., Almeda‐Valdés, P., Gómez-Munguía, L., Chávez, X. R.-D., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01436-6 · Cited by 22
Guo, T., Yin, R., Pan, L., Yang, S., Miao, L., & Huang, F. (2017) · Scientific Reports · doi:10.1038/srep45119 · Cited by 16
Larifla, L., Rambhojan, C., Joannes, M.-O., Maimaitiming-Madani, S., Donnet, J., Marianne-Pépin, T., Chout, R., Roussel, R., & Foucan, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163421 · Cited by 14
Joint Associations of APOC3 and LDL-C–Lowering Variants With the Risk of Coronary Heart Disease
Wang, W., Li, R. P., Song, Z., Huang, N., Huang, T., Hua, X., & Tang, Y.-D. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.0195 · Cited by 16
Huang, Z., Xu, Z., Xu, R., Huang, L., Xu, X. Y., & Lai, X. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13100 · Cited by 15
Caddeo, A. M., Mancina, R. M., Pirazzi, C., Russo, C., Sasidharan, K., Sandstedt, J., Maurotti, S., Montalcini, T., Pujia, A., Leren, T. P., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.11.003 · Cited by 18
Wang, J., Sun, X., Jiao, L., Xiao, Z., Riaz, F., Zhang, Y., Xu, P., Liu, R., Tang, T., Liu, M., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.916672 · Cited by 16
Yu, L., Sun, X., Wang, P., Chi, J., Hou, X., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17762 · Cited by 14
Primary Hypertriglyceridemia: A Look Back on the Clinical Classification and Genetics of the Disease
Musambil, M., Al-Rubeaan, K. A., Al-Qasim, S., Alnaqeb, D., & Al-Soghayer, A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666190502164131 · Cited by 16
Polygenic Risk of Hypertriglyceridemia Is Modified by BMI
Esteve-Luque, V., Fanlo‐Maresma, M., Padró‐Miquel, A., Corbella, E., Rivas-Regaira, M., Pintó, X., & Candás‐Estébanez, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179837 · Cited by 13
Mszar, R., Bart, S., Sakers, A. P., Soffer, D. E., & Karalis, D. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041382 · Cited by 17
Recent advances in cytoplasmic lipid droplet metabolism in intestinal enterocyte
Ghanem, M., Lewis, G. F., & Xiao, C. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159197 · Cited by 15
Self-citationCarpentier, A. C. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306412 · Cited by 15
Morkos, M., Amblee, A. P., Henriquez, A., Basu, S., & Fogelfeld, L. A. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0599 · Cited by 11
Syed‐Abdul, M. M., Stahel, P., Tian, L., Xiao, C., Nahmias, A., & Lewis, G. F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159194 · Cited by 13
Self-citationFanlo‐Maresma, M., Esteve-Luque, V., Pintó, X., Padró‐Miquel, A., Corbella, E., & Candás‐Estébanez, B. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2022-000774 · Cited by 11
Syed‐Abdul, M. M., Stahel, P., Zembroski, A. S., Tian, L., Xiao, C., Nahmias, A., Bookman, I. D., Buhman, K. K., & Lewis, G. F. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac690 · Cited by 11
Self-citationFanlo‐Maresma, M., Candás‐Estébanez, B., Esteve-Luque, V., Padró‐Miquel, A., Escrihuela-Vidal, F., Carratini-Moraes, M., Corbella, E., Corbella, X., & Pintó, X. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102218 · Cited by 12
Cabello, I., Alia, P. J., Pintó, X., Muniesa, C., Fernández‐de‐Misa, R., Peñate, Y., Morillo, M., Perez-Farriols, A., Estrach, T., Izu, R., et al. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.3679 · Cited by 11
Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy
Aslesh, T., & Yokota, T. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0771-8_5 · Cited by 11
Metabolismo de los triglicéridos y clasificación de las hipertrigliceridemias
Ibarretxe, D., & Masana, L. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.02.004 · Cited by 19
Environmental and epigenetic regulation of postprandial lipemia
Parnell, L. D., Ordovás, J. M., & Lai, C. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000469 · Cited by 14
Zheng, H., Wang, D., Wang, X., Lin, Y., Lu, Z., Chen, Y., Feng, G., & Yang, N. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01383-8 · Cited by 9
Sviridov, D. O., Dasseux, A., Reimund, M., Pryor, M., Drake, S. K., Jarin, Z., Wolska, A. T., Pastor, R. W., & Remaley, A. T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1223920 · Cited by 9
Hipertrigliceridemia familiar/hipertrigliceridemia poligénica
Lahoz, C., & Mostaza, J. M. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.12.014 · Cited by 11
Combined Dyslipidemia in Children and Adolescents
Kavey, R.-E. W. (2016) · Cited by 9
Genetic risk scores in lipid disorders
Wierzbicki, A. S., & Reynolds, T. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000623 · Cited by 10
Xenoulis, P. G., Tate, N. M., Bishop, M. A., Steiner, J. M., Suchodolski, J. S., & Furrow, E. (2020) · The Veterinary Journal · doi:10.1016/j.tvjl.2020.105559 · Cited by 8
Tillo, M., Lamanna, W. C., Dwyer, C. A., Sandoval, D. R., Pessentheiner, A. R., Al-Azzam, N., Sarrazin, S., Gonzales, J. C., Kan, S., Andreyev, A. Y., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102159 · Cited by 8
Pisciotta, L., Vitali, C., Favari, E., Fossa, P., Adorni, M. P., Leone, D., Artom, N., Fresa, R., Calabresi, L., Calandra, S., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.09.001 · Cited by 7
Role of sulfatase 2 in lipoprotein metabolism and angiogenesis
Dallinga, M. G., & Dallinga‐Thie, G. M. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000271 · Cited by 8
Study on the association of hypertriglyceridemia with hypertensive states of pregnancy
Serrano-Berrones, M. Á., & Barragán-Padilla, S. B. (2019) · Gaceta Médica de México · doi:10.24875/gmm.m19000284 · Cited by 7
Angeborene Störungen im Lipoproteinstoffwechsel
März, W., Grammer, T. B., Delgado, G., & Kleber, M. E. (2017) · Herz · doi:10.1007/s00059-017-4578-x · Cited by 7
Adeli, K., Taher, J., Farr, S., Xiao, C., & Lewis, G. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63438-2.00019-5 · Cited by 6
Self-citationThe Genetic Spectrum of Familial Hypertriglyceridemia in Oman
Al-Waili, K., Al‐Rasadi, K., Al-Bulushi, M., Habais, M., Al-Mujaini, A. S., Al-Yaarubi, S., Rimbert, A., Zadjali, R., Khaniabadi, P. M., Al-Barwani, H., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.886182 · Cited by 6
Hu, Y., Zhang, G., Yang, Q., Pu, N., Li, K., Li, B., Cooper, D. N., Tong, Z., Li, W., & Chen, J. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01875-3 · Cited by 6
Castelo, M. H. C. G., Montenegro, R. M., Ponte, C. M. M., Sousa, T. C. S., Silva, P. G. B., Belém, L. D. S., Furtado, F. L. B., Batista, L. A. D. A., Pereira, A. C., & Santos, R. D. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0605-4 · Cited by 7
Metadata
- Authors
- Lewis, G. F., Xiao, C., & Hegele, R. A.
- Affiliations
- University of Toronto (CA)
- Western University (CA)
- Corresponding author
- Lewis, Gary F.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2015-02-01
- Volume
- 36
- Issue
- 1
- Pages
- 131-147
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2142850613
- Cited by
- 152
- References
- 113
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 14 · 2023: 9 · 2022: 14 · 2021: 19 · 2020: 22 · 2019: 17 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 8
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Genome Canada
- Canadian Institutes of Health Research (79533, MOP‑79533), MOP13430, MOP-43839)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypertriglyceridemia, triglyceride-rich lipoproteins, remnant lipoproteins, genetic susceptibility, polygenic inheritance, familial combined hyperlipidemia, familial hypertriglyceridemia, metabolic syndrome, insulin resistance, LDL cholesterol, gene-environment interaction, cardiovascular risk, dyslipidemia
- MeSH terms
- Alcohol Drinking, Diabetes Mellitus, Type 2, Environment, Female, Humans, Insulin Resistance, Life Style, Lipoproteins, Male, Metabolic Clearance Rate, Middle Aged, Nephrotic Syndrome, Phenotype, Pregnancy, Pregnancy Complications, Risk Factors, Triglycerides, Genetic Variation, Hypertriglyceridemia, Genetic Predisposition to Disease, Metabolic Syndrome, Atherosclerosis, Renal Insufficiency, Chronic, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.